These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 779340)

  • 1. [Gold treatment of progressive chronic polyarthritis--a clinical study].
    Knoche U; Wagner H; Hauss WH
    Z Rheumatol; 1975; 34(5-6):203-12. PubMed ID: 779340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Sulfasalazine (Azulfidine RA) versus aurothioglucose in therapy of chronic polyarthritis--status report of an open, comparative, multicenter long-term study].
    Schattenkirchner M
    Z Rheumatol; 1987; 46(2):67-70. PubMed ID: 2885986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One-year comparative study of gold sodium thiomalate and auranofin in the treatment of rheumatoid arthritis.
    Davis P; Menard H; Thompson J; Harth M; Beaudet F
    J Rheumatol; 1985 Feb; 12(1):60-7. PubMed ID: 3920393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy and safety of auranofin compared to placebo in rheumatoid arthritis.
    Katz WA; Alexander S; Bland JH; Blechman W; Bluhm GB; Bonebrake RA; Falbo A; Greenwald RA; Hartman S; Hobbs T; Indenbaum S; Lergier JE; Lanier BG; Lightfoot RW; Phelps P; Sheon RP; Torretti D; Wenger ME; Wilske K
    J Rheumatol Suppl; 1982; 8():173-8. PubMed ID: 6813481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aurothioglucose in rheumatoid arthritis. Outcome of treatment in patients intolerant of sodium aurothiomalate.
    McGirr EE; Browne CD; Champion GD; Day RO; Sambrook PN
    Med J Aust; 1984 Sep; 141(6):349-51. PubMed ID: 6438454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Auranofin treatment for adult rheumatoid arthritis. Comparison of 2 mg and 6 mg daily dose.
    Bernhard GC
    J Rheumatol Suppl; 1982; 8():149-53. PubMed ID: 6813477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Experiences to date with oral gold therapy].
    Zeidler H
    Wien Klin Wochenschr Suppl; 1984; 156():22-7. PubMed ID: 6442052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Dynamics of immune response parameters and the therapeutic effect of gold salts in patients with rheumatoid arthritis].
    Dilas D; Lilić D; Dujić A; Dimitrijević D
    Lijec Vjesn; 1984; 106(7-8):276-81. PubMed ID: 6443578
    [No Abstract]   [Full Text] [Related]  

  • 9. [Indications and contraindications for systemic gold therapy].
    Schattenkirchner M
    Wien Klin Wochenschr Suppl; 1984; 156():3-7. PubMed ID: 6442054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of rheumatoid arthritis with gold.
    Liang GC
    Wis Med J; 1978 Aug; 77(8):S71-2. PubMed ID: 99882
    [No Abstract]   [Full Text] [Related]  

  • 11. Auranofin and sodium aurothiomalate in the treatment of rheumatoid arthritis. A double-blind, comparative multicenter study.
    Schattenkirchner M; Kaik B; Muller-Fassbender H; Rau R; Zeidler H
    J Rheumatol Suppl; 1982; 8():184-9. PubMed ID: 6813483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Change in functional capacity and pain intensity of 81 cP patients treated with Azulfidine RA or aurothioglucose. Preliminary statistical assessment of the German multicenter study of the treatment of chronic polyarthritis with Azulfidine RA].
    Raspe HH; Kindel P; Vesterling K; Kohlmann T
    Z Rheumatol; 1987; 46(2):71-5. PubMed ID: 2885987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Gold therapy in chronic polyarthritis. Differentiation of allergic and toxic side effects].
    Bene E; Megyeri A; Györi J
    Z Rheumatol; 1980; 39(3-4):109-16. PubMed ID: 6448525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of the benefits and risks in the treatment of chronic juvenile arthritis with gold salts].
    Mesihović H; Trebinjac S; Mesihović S; Buljina A
    Lijec Vjesn; 1991; 113(11-12):420-2. PubMed ID: 1669615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Modifications in alpha 2 globulins, gamma globulins and in rheumatoid factor during gold salt therapy in rheumatoid arthritis].
    Gropuzzo M; Masoch G; Gambari PF; Todesco S
    Boll Soc Ital Biol Sper; 1978 Dec; 54(23):2435-9. PubMed ID: 92320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High dose, low frequency parenteral gold administration.
    Norton WL; Donnelly RJ
    J Rheumatol; 1983 Jun; 10(3):454-8. PubMed ID: 6411920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind study comparing sodium aurothiomalate and auranofin in patients with rheumatoid arthritis previously stabilized on sodium aurothiomalate.
    Hull RG; Morgan SH; Parke AL; Childs L; Goldman M; Hughes GR
    Int J Clin Pharmacol Res; 1984; 4(6):395-401. PubMed ID: 6442711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term treatment of rheumatoid arthritis with fenclofenac or gold: a controlled, single blind trial comparing clinical and biochemical parameters.
    Lund B; Graae A; Sonne I; Andersen RB
    Eur J Rheumatol Inflamm; 1983; 6(3):279-87. PubMed ID: 6391933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucocutaneous reactions to gold: a prospective study of 74 patients with rheumatoid arthritis.
    van Gestel A; Koopman R; Wijnands M; van de Putte L; van Riel P
    J Rheumatol; 1994 Oct; 21(10):1814-9. PubMed ID: 7837143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Injectable gold dermatitis and proteinuria: retreatment with auranofin.
    Tosi S; Cagnoli M; Guidi G; Murelli M; Messina K; Colombo B
    Int J Clin Pharmacol Res; 1985; 5(4):265-8. PubMed ID: 2932399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.